Provides safety and security to you and your arthroplasty patients in the outpatient setting
Helps you navigate medical risk assessment and clearance for your outpatient arthroplasty patients
Safely allows you to expand your outpatient arthroplasty program
Significantly more predictive than ASA
Each assessment takes only seconds to complete
Determining the Validity of the Outpatient Arthroplasty Risk Assessment Tool (OARA) for Identifying Patients for Safe Same-Day Discharge after Primary Shoulder Arthroplasty - Read Study...
Outpatient Joint Arthroplasty—Patient Selection: Update on the Outpatient Arthroplasty Risk Assessment Score - Read Study...
Rapid Discharge in Total Hip Arthroplasty: Utility of the Outpatient Arthroplasty Risk Assessment Tool in Predicting Same-Day and Next-Day Discharge - Read Study...
Safe Selection of Outpatient Joint Arthroplasty Patients With Medical Risk Stratification: the “Outpatient Arthroplasty Risk Assessment Score” - Read Study...
Risk stratification tool designed to help reduce burden on hospitals by helping surgeons transition more total joint arthroplasty cases to outpatient or same-day discharge. - Read More...
Burbank, CA surgical practice adopts the DJO® OaraScore™ to ensure patient safety for outpatient joint replacement procedures. - Read More...
DJO, a leading provider of medical technologies designed to get and keep people moving, announced today the availability of the industry’s first Outpatient Arthroplasty Risk Assessment tool, the OaraScore™. The easy-to-use software tool provides medical professionals with the information needed to assess the appropriate post-operative length of stay after total joint arthroplasty (TJA). - Read More...
DJO’s OaraScore Tool May Help Determine Total Knee Outpatient Risk - Read More...
DJO announces outpatient arthroplasty risk assessment tool at AAHKS - Read More...
DJO Debuts OaraScore Risk Assessment Tool for Outpatient Joint Arthroplasty - Read More...
DJO launches 1st outpatient arthroplasty risk assessment tool - Read More...
*Compared to ASA Certification: Meneghini, M., Ziemba-Davis, M., Ishmael., Kuzma, A. and Peter Caccavallo. (November 2015). “Safe Selection of Outpatient Joint Replacement Patients with Medical Risk Stratification: The “OARA Score”.” Paper presented at the 2015 AAHKS Annual Meeting, Dallas, Texas. Abstract retrieved from http://meeting.aahks.net/wp-content/ uploads/2015/11/paper-45-meneghini.pdf
This Outpatient Arthroplasty Risk Assessment (“Oara”) Score is a general guide based on medical co-morbidities and other health factors. The score has been developed to help determine a patient’s likelihood of being able to undergo total hip or total knee replacement as an outpatient with a discharge either the same day or within 24 hours of surgery.
The OaraScore® is NOT to be used as the sole method for determining whether a patient is appropriate for hip or knee arthroplasty in the outpatient setting. The OaraScore is NOT a predictor of postoperative medical or surgical complications. The OaraScore is NOT a predictor of morbidity or mortality after hip or knee replacement surgery. Further, the OaraScore is NOT a predictor of readmission after arthroplasty surgery. The OaraScore should be used in conjunction with thorough assessment by the orthopaedic surgeon and perioperative medical experts, in order to determine if patients are appropriate for hip or knee replacement in the outpatient setting. addition, the OaraScore does NOT determine whether a surgery should be performed in an ambulatory surgery center or a hospital setting, as this decision resides solely with the individual surgeon familiar with his/her own patient care environment.
The developers of the OaraScore recommend the OaraScore be used as part of a comprehensive outpatient surgery program that is multi-disciplinary and focuses on patient safety. Each surgeon must also evaluate his/her own surgical ability and outcomes to determine whether he/she is capable of performing surgery safely in the outpatient setting. Prolonged surgery times, excessive blood loss and/or greater than expected surgical and soft-tissue trauma may diminish the OaraScore’s ability to reliably predict an expedited discharge home. The OaraScore was developed and validated in a model with fellowship-trained hip and knee arthroplasty surgeons who are efficient surgically, have a comprehensive multi-modal pain program, have highly skilled and trained staff for enhanced communication with patients and a robust educational program for patients and family considering arthroplasty surgery in the outpatient setting.
DJO Surgical® is a manufacturer of orthopedic implants and does not practice medicine. Only an orthopedic surgeon can determine what treatment is appropriate. Individual results of total joint replacement may vary. The life of any implant will depend on the patient’s weight, age, activity level, and other factors.
Individual results may vary.
Neither DJO, LLC nor any of its subsidiaries dispense medical advice. The contents of this website do not constitute medical, legal, or any other type of professional advice. Information related to various health, medical, and fitness conditions and their treatment is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you.
Some of the products advertised on this website may not be licensed in accordance with Canadian law.
This site collects information about you. To learn more about what we collect and how we use that information, see our Privacy Policy. If you do not wish DJO, LLC to share your information with our partners, please make adjustments in our Privacy Policy section.